[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Insider shares were acquired as compensation via restricted stock vesting, indicating alignment with company incentive programs
• Transaction size is immaterial relative to outstanding shares, minimizing potential dilution or market impact

Negative

• Insider has executed multiple recent sales totaling 2,391 shares for $65,139.96, which may be viewed as insider liquidity
• Filing provides no additional context about the reason for sales beyond standard Rule 144 disclosure

Insights

Financial Analyst

TL;DR: Insider vested 940 shares and plans to sell; recent sales totaled 2,391 shares for $65,139.96—transaction size is immaterial to market cap.

The filing documents a planned sale of 940 shares acquired via restricted stock vesting on 09/11/2025 with an indicated sale date of 09/16/2025 through Fidelity. Given the company's stated outstanding share count of 59,914,473, the 940-share proposed sale and the recent 2,391-share disposals represent a negligible fraction of outstanding equity (well under 0.01%). There are no financial results, forward guidance, or new financing items disclosed here. This is a routine Rule 144 notice reflecting insider liquidity from vested compensation rather than a corporate operational development.

Corporate Governance Expert

TL;DR: The filing is a standard compliance disclosure for insider sales tied to vesting; no governance red flags are identified in the notice.

The document provides required seller representations and notes no known undisclosed material adverse information. The securities were acquired as compensation and the filer executed prior small open-market sales in July 2025. The filing follows Rule 144 mechanics; there is no indication of unusual trading patterns, large block sales, or exceptions that would raise immediate governance concerns based on the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	940	21887.34	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			940	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/07/2025	571	16473.35
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/15/2025	307	8371.83
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/16/2025	422	11372.90
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	465	12501.90
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/18/2025	626	16419.98

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 report?

The Form 144 notifies a proposed sale of 940 common shares (approximate market value $21,887.34) with an approximate sale date of 09/16/2025 on the NYSE.

How were the 940 shares acquired for the planned sale?

The shares were acquired on 09/11/2025 via restricted stock vesting and the nature of payment is listed as compensation.

Who is the broker handling the proposed sale?

The broker named in the filing is Fidelity Brokerage Services LLC located at 900 Salem Street, Smithfield, RI.

Has the filer sold shares recently?

Yes; the filer sold 2,391 shares between 07/07/2025 and 07/18/2025, generating total gross proceeds of $65,139.96.

What share count does the filing report as outstanding?

The filing reports 59,914,473 shares outstanding for the issuer.